Depending on the expression of molecular biomarkers, including estrogen receptor (ER), progesterone receptor (PgR), and human epidermal growth factor receptor 2 (HER2), BC can be categorized into different subtypes [6]. This evidence concerns the gene ERBB2 and breast cancer.